MedEquities Realty Trust (MRT) Cut to Hold at Zacks Investment Research

Zacks Investment Research lowered shares of MedEquities Realty Trust (NYSE:MRT) from a buy rating to a hold rating in a research report report published on Saturday.

According to Zacks, “MedEquities Realty Trust, Inc. owns, develops, operates, leases and disposes healthcare properties and portfolios. It operates primarily in Texas, California, Nevada and South Carolina. MedEquities Realty Trust, Inc. is based in Nashville, Tennessee. “

MRT has been the subject of a number of other research reports. ValuEngine downgraded MedEquities Realty Trust from a hold rating to a sell rating in a research note on Wednesday, May 2nd. B. Riley set a $12.00 price target on MedEquities Realty Trust and gave the company a buy rating in a research note on Thursday. KeyCorp cut their price target on MedEquities Realty Trust from $13.00 to $12.00 and set an overweight rating for the company in a research note on Monday, April 16th. JMP Securities set a $13.00 price target on MedEquities Realty Trust and gave the company a buy rating in a research note on Friday, May 11th. Finally, Canaccord Genuity cut their price target on MedEquities Realty Trust from $13.00 to $12.00 and set an overweight rating for the company in a research note on Thursday. One research analyst has rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the company’s stock. MedEquities Realty Trust currently has a consensus rating of Hold and an average target price of $12.22.

Shares of MRT traded down $0.21 during trading hours on Friday, hitting $9.96. The stock had a trading volume of 113,788 shares, compared to its average volume of 100,020. The company has a market cap of $324.04 million, a PE ratio of 8.74 and a beta of -0.11. MedEquities Realty Trust has a 1-year low of $9.67 and a 1-year high of $12.05.

MedEquities Realty Trust (NYSE:MRT) last issued its earnings results on Wednesday, August 8th. The financial services provider reported $0.10 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.30 by ($0.20). The firm had revenue of $17.56 million during the quarter, compared to analyst estimates of $17.03 million. MedEquities Realty Trust had a net margin of 30.84% and a return on equity of 5.73%. equities research analysts predict that MedEquities Realty Trust will post 1.21 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, August 29th. Shareholders of record on Wednesday, August 15th will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Tuesday, August 14th. This represents a $0.84 annualized dividend and a dividend yield of 8.43%. MedEquities Realty Trust’s dividend payout ratio is currently 73.68%.

In other MedEquities Realty Trust news, Director Bluemountain Capital Managemen sold 19,316 shares of MedEquities Realty Trust stock in a transaction that occurred on Monday, May 14th. The shares were sold at an average price of $10.48, for a total transaction of $202,431.68. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In the last three months, insiders have sold 165,564 shares of company stock worth $1,712,407. Insiders own 2.50% of the company’s stock.

Several institutional investors have recently bought and sold shares of MRT. Wells Fargo & Company MN lifted its position in shares of MedEquities Realty Trust by 93.1% during the 4th quarter. Wells Fargo & Company MN now owns 68,306 shares of the financial services provider’s stock worth $767,000 after buying an additional 32,940 shares in the last quarter. BlackRock Inc. raised its holdings in shares of MedEquities Realty Trust by 2.3% in the 4th quarter. BlackRock Inc. now owns 1,424,525 shares of the financial services provider’s stock worth $15,984,000 after purchasing an additional 32,289 shares during the period. Geode Capital Management LLC raised its holdings in shares of MedEquities Realty Trust by 43.9% in the 4th quarter. Geode Capital Management LLC now owns 349,783 shares of the financial services provider’s stock worth $3,923,000 after purchasing an additional 106,727 shares during the period. Renaissance Technologies LLC raised its holdings in shares of MedEquities Realty Trust by 2.7% in the 4th quarter. Renaissance Technologies LLC now owns 439,400 shares of the financial services provider’s stock worth $4,930,000 after purchasing an additional 11,700 shares during the period. Finally, Teachers Advisors LLC raised its holdings in shares of MedEquities Realty Trust by 15.7% in the 4th quarter. Teachers Advisors LLC now owns 82,692 shares of the financial services provider’s stock worth $928,000 after purchasing an additional 11,244 shares during the period. 91.65% of the stock is currently owned by hedge funds and other institutional investors.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Featured Article: Growth Stocks

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply